Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Blockade of VEGF alone is sufficient to prevent blinding illness

Feb. 21, 2000

Novel Merck compounds inhibit KDR kinase and VEGF activity

Feb. 15, 2000

Ophthalmic antibacterial on the way to market in Japan

Feb. 15, 2000

FDA issues approvable letter for Visudyne

Feb. 14, 2000

New ophthalmic gene licensed by InSite

Feb. 10, 2000

Oculex updates intraocular drug delivery pipeline

Feb. 4, 2000

Visudyne market introduction announced

Feb. 2, 2000

Are cannabinoid receptors involved in the IOP-lowering effects of cannabinoids?

Feb. 2, 2000

InSite Vision licenses novel TIGR modifier gene

Feb. 2, 2000

Alcon makes milestone payment to Pharmacyclics for Optrin

Feb. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...